|
|
 |
|
Viewing report
|
|
|
|
Disease and Therapy Review: Cervical Cancer
Timely Data Resources, Inc., Sep 2008, Pages: 12
The Cervical Cancer Disease and Therapy Review provides incidence and prevalence numbers and percentages for major countries worldwide, 5-year survival rates by stage, and information on diagnosis, staging, and an overview of treatments for prevention, emergency measures and specific measures such as carcinoma in situ, invasive carcinoma and complications. Dosing and treatment cost information is provided for surgical therapy, radiation therapy, and chemotherapy. General information on the US market size, with comments about continuing research and the new HPV vaccine are also provided.
Disease and Therapy Reviews were developed to provide a basic understanding of the key facts about a disease and market in a quick, easy-to-read format. These reports are prepared by the senior market research team of Timely Data Resources. Each Disease and Therapy Review provides a concise analysis of the most important information about a particular disease, its treatment, and the market opportunities. Reports begin with an overview of the condition, and also contain tables that summarize the available worldwide incidence and prevalence data for the condition, a review of current diagnosis strategies and treatment options, general information about the market size, and information about important market trends. The data contained in these reports comes from key industry secondary data sources, such as the Timely Data Resources Incidence and Prevalence Database, and Langes Current Medical Diagnosis and Treatment. This information is supplemented by reviews of analyst reports, company reports, and medical websites. Sources and references are provided.
Customers who bought this item also bought
Cervical Cancer: Is Society Ready For a Preventative Answer?
Disease Specific Markers Clinical Trial Analysis
Managing Physical/Occupational/Speech Therapy & Rehabilitation Care, 7th Edition (2009)
Disease State Management Strategies I Clinical Guidelines for Primary Care 3nd Edition (2009 Update)
Stakeholder Opinions: Gynecological Cancers - Niche Opportunities in Advanced Disease
Artificial Disc Replacement Clinical Trial Analysis
Spinal Non-Fusion Clinical Trial Analysis
Qiagen N.V. Product Pipeline Analysis
U.S. Markets for Spinal Disc Repair and Replacement Technologies
Cancer Therapeutics Markets
Spinal Surgery Clinical Trial Analysis
Deep Brain Stimulators Clinical Trial Analysis
|
|
|
|
